Famotidine Powder, For Suspension
Product Images NDC 70377-113

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Famotidine (NDC 70377-113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocon Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemstructure (Chemstructure)

Chemical structure of famotidine, showing the molecular arrangement of atoms including sulfur, nitrogen, and oxygen components in the compound.*

FDA Label Image

Containerlabel (Containerlabel)

Label for Famotidine for Oral Suspension USP 40 mg/5 mL powder for suspension, containing 400 mg of famotidine per bottle when reconstituted. The 50 mL bottle is for oral use only and must be shaken well before use. Manufactured by Carnegie Pharmaceuticals LLC and labeled for Biocon Pharma Inc. The label includes directions for reconstitution, storage, inactive ingredients, and patient notices.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.